Finnish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Wiadomosci Lekarskie 2003

[Selected risk factors of thrombotic complications in patients with ulcerative colitis].

Vain rekisteröityneet käyttäjät voivat kääntää artikkeleita
Kirjaudu sisään Rekisteröidy
Linkki tallennetaan leikepöydälle
Antoni Stadnicki
Barbara Bojko
Kinga Myczkowska
Justyna Witalińska-Łabuzek

Avainsanat

Abstrakti

We have analyzed the prothrombotic risk factors in 124 patients with ulcerative colitis (UC) as compared with control subjects with other gastrointestinal disorders. The patients were hospitalized from 1991 to 2000 in the Department of Internal Medicine. Platelets level was significantly higher (p < 0.001) in UC patients as compared with control group, and aPTT was significantly (p < 0.05) prolonged respectively in UC patients as compared with control group. In the prospective pilot study we observed the decrease of plasma antithrombin level and/or decrease of protein S in approximately 22% of UC patients. The plasma protein C activity was normal in all UC patients, whereas the mean level of protein S was significantly lower (p < 0.02) in UC patients as compared with controls. Thus our data indicate that coagulation abnormalities are potential risk factors of thromboembolic complications in UC. Plasma cholesterol and triglyceride levels were above upper limit of normal values in 38% and 18% UC patients respectively, but mean values of both parameters were not significantly different between UC and control group. Our results suggest that plasma lipid changes are not independent risk factor of vascular complication in UC. In UC patients smokers were observed 4 times less than no-smokers. However, positive correlation between smoking and rise of hematocrit (F = 4.48; p < 0.05) in UC suggests that smoking may be a risk factor of vascular complications in the disease. Thromboembolic events were found in 1.6% of UC patients. In addition, chronic coronary heart disease was accompanied approximately 6% of UC patients. Evaluation of prothrombotic risk factors and associated ischaemic heart diseases may have prognostic value in the management of UC.

Liity facebook-sivullemme

Täydellisin lääketieteellinen tietokanta tieteen tukemana

  • Toimii 55 kielellä
  • Yrttilääkkeet tieteen tukemana
  • Yrttien tunnistaminen kuvan perusteella
  • Interaktiivinen GPS-kartta - merkitse yrtit sijaintiin (tulossa pian)
  • Lue hakuusi liittyviä tieteellisiä julkaisuja
  • Hae lääkekasveja niiden vaikutusten perusteella
  • Järjestä kiinnostuksesi ja pysy ajan tasalla uutisista, kliinisistä tutkimuksista ja patenteista

Kirjoita oire tai sairaus ja lue yrtteistä, jotka saattavat auttaa, kirjoita yrtti ja näe taudit ja oireet, joita vastaan sitä käytetään.
* Kaikki tiedot perustuvat julkaistuun tieteelliseen tutkimukseen

Google Play badgeApp Store badge